
Presight Capital
Financial History
Leadership Team
Key people at Presight Capital.

Key people at Presight Capital.
Key people at Presight Capital.
Presight Capital is a global venture capital firm founded in 2019 by Christian Angermayer in partnership with Apeiron Investment Group, headquartered in West Hollywood, California. The firm manages over $600 million in assets and invests across multiple stages, from seed to IPO, focusing on transformative sectors including biotechnology, healthcare, fintech, consumer products, deep tech, food tech, and cryptocurrency. Its mission is to support ambitious founders by providing capital, strategic advice, and connections, emphasizing breakthrough technologies and innovative solutions. Notable portfolio companies include ATAI Life Sciences, AbCellera, Compass Pathways, General Fusion, and Perfect Day, reflecting a strong presence in mental health, biotech, and sustainable food tech[1][2].
Presight Capital was launched in 2019 by Christian Angermayer, an entrepreneur and investor, with the backing of Apeiron Investment Group. Since inception, it has evolved into a full lifecycle investor with a multi-sector approach, deploying investment tickets ranging from $500K to $20M. The firm has expanded its portfolio to over 80 companies across more than eight sectors, including several unicorns and public listings. Its growth trajectory includes closing a $350 million second fund shortly after an initial $80 million fund, demonstrating rapid scaling and increased market influence[1][2][3].
Presight Capital rides the wave of increasing interest in deep tech, biotech, mental health innovation, and sustainable technologies. The timing aligns with growing global demand for advanced healthcare solutions, alternative food sources, and fintech innovation. Market forces such as rising healthcare needs, environmental concerns, and digital transformation favor Presight’s investment thesis. By backing companies at the forefront of these trends, Presight influences the startup ecosystem by accelerating the development and commercialization of disruptive technologies worldwide[1][2].
Looking ahead, Presight Capital is poised to continue expanding its portfolio in high-impact sectors, leveraging its full lifecycle investment approach and global network. Trends such as personalized medicine, sustainable consumer products, and decentralized finance will likely shape its future investments. As the firm scales, its influence on the venture ecosystem is expected to grow, potentially driving more startups toward breakthrough innovations and public market success. Presight’s commitment to outlier entrepreneurs positions it well to capitalize on emerging opportunities and maintain leadership in multi-sector venture investing[1][2][3].